Ahn-Gook Pharmaceutical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 0.00012 million compared to KRW 0.00011 million a year ago. Net income was KRW 1,410.85 million compared to KRW 262.02 million a year ago. Basic earnings per share from continuing operations was KRW 123 compared to KRW 23 a year ago. Diluted earnings per share from continuing operations was KRW 123 compared to KRW 23 a year ago. Basic earnings per share was KRW 123 compared to KRW 23 a year ago.
For the nine months, negative sales was KRW 0.00018 million compared to sales of KRW 0.0004 million a year ago. Net income was KRW 798.4 million compared to net loss of KRW 1,907.89 million a year ago. Basic earnings per share from continuing operations was KRW 70 compared to basic loss per share from continuing operations of KRW 166 a year ago. Diluted earnings per share from continuing operations was KRW 70 compared to diluted loss per share from continuing operations of KRW 166 a year ago. Basic earnings per share was KRW 70 compared to basic loss per share of KRW 166 a year ago.